10-09-2007 Comments (0)
Amlodipine and Olmesartan Medoxomil TabletsAriceptAtacandAzorBenicarCandesartan CilexetilDaiichi SankyodonepezilEisaiForest LaboratoriesHumulin 70-30Humulin NHumulin RInsulinIpsenLillyolmesartanPfizerRocheSankyo
Tokyo rebounded moderately in the week ended September 3. The Nikkei 225 gained 1.4% to recover the 16,500…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.